Results 301 to 310 of about 1,859,821 (399)

Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study. [PDF]

Sci Rep
Morikawa K, Suzuki Y, Kato S, Kono M, Hashimoto D, Yokomura K, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T.   +14 more
europepmc   +1 more source

Fuzheng Huayu tablets for treating pulmonary fibrosis in post-COVID-19 patients: a multicenter, randomized, double-blind, placebo-controlled trial

Fei Jing, Wei Wang, Jia Ke, Tingrong Huang, Bo Jiang, Qiwu Qiu, Jihan Huang, Songhua Zhan, Wei Zhang, Hui Wu, Wen Su, Jiawen Feng, Peng Yuan, Zhimin Zhao, Feng Xing, Chenghai Liu   +15 more
openalex   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

British Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki, Kiplin A. Patanwala, Jan‐Willem C. Alffenaar, Asad E. Patanwala   +3 more
wiley   +1 more source

Vascular etiologies of unilateral pulmonary fibrosis: Case series and literature overview. [PDF]

Radiol Case Rep
Cozzi D, Gozzi L, Cavigli E, Moroni C, Bindi A, Rosi E, Tomassetti S, Miele V.   +7 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

CILP attenuates pulmonary fibrosis through the TGF-β1/SMAD3 pathway. [PDF]

Eur J Med Res
Zou H, Dong J, Zhao R, Liu F, Cheng J, Li X, Fei C, Li P, Liu C.   +8 more
europepmc   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Chemerin in Pulmonary Fibrosis: Advances in Mechanistic and Fundamental Research. [PDF]

Biomolecules
Jiang Y, Li Z, Huang Z, Dong J, Qian L.
europepmc   +1 more source

Fractal Anatomy of Human Organs: A Narrative Review of Structure, Function, and Clinical Perspectives

Clinical Anatomy, EarlyView.
ABSTRACT Fractal geometry describes complex, self‐similar patterns that repeat across spatial scales and is increasingly recognized as relevant in anatomical research. Indeed, the fractal organization is consistently observed in respiratory, cardiovascular, gastrointestinal, nervous, renal, hepatic, and dermatological systems.
Immacolata Belviso, Jacopo Junio Valerio Branca, Giulia Guarnieri, Annamaria Morelli, Alessandra Pacini, Daniele Della Posta, Domenico Ribatti, Ferdinando Paternostro   +7 more
wiley   +1 more source

Comparison of the Efficacy of Pirfenidone and Nintedanib in the Treatment of Patients with Idiopathic Pulmonary Fibrosis-A Single-Center Experience. [PDF]

Medicina (Kaunas)
Trboljevac N, Dimic-Janjic S, Kontic M, Omcikus M, Ilic B, Markovic F, Postic A, Isovic L, Stjepanovic M, Nenezic D.   +9 more
europepmc   +1 more source